These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38104911)

  • 1. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
    Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale.
    Garon M; Weis L; Siquier A; Fiorenzato E; Pistonesi F; Cianci V; Canesi M; Pesce F; Reali E; Pozzi B; Isaias IU; Siri C; Santangelo G; Cuoco S; Barone P; Kulisevsky J; Antonini A; Biundo R
    J Neural Transm (Vienna); 2024 Apr; 131(4):305-314. PubMed ID: 38280057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment.
    Simon-Gozalbo A; Rodriguez-Blazquez C; Forjaz MJ; Martinez-Martin P
    Front Neurol; 2020; 11():731. PubMed ID: 32849203
    [No Abstract]   [Full Text] [Related]  

  • 4. Visualization of Focal Thinning of the Ganglion Cell-Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Shao Y; Jiang H; Wei Y; Shi Y; Shi C; Wright CB; Sun X; Vanner EA; Rodriguez AD; Lam BL; Rundek T; Baumel BS; Gameiro GR; Dong C; Wang J
    J Alzheimers Dis; 2018; 64(4):1261-1273. PubMed ID: 30040712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular Ganglion Cell -Inner Plexiform Layer Thickness Is Associated with Clinical Progression in Mild Cognitive Impairment and Alzheimers Disease.
    Choi SH; Park SJ; Kim NR
    PLoS One; 2016; 11(9):e0162202. PubMed ID: 27598262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the Random Forest Algorithm Suitable for Predicting Parkinson's Disease with Mild Cognitive Impairment out of Parkinson's Disease with Normal Cognition?
    Byeon H
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
    J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Quality of Life According to Cognitive Status in Parkinson's Disease.
    Fan Y; Liang X; Han L; Shen Y; Shen B; Chen C; Sun Y; Wang J; Tang Y
    Front Aging Neurosci; 2020; 12():269. PubMed ID: 32973491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment.
    Samat NA; Abdul Murad NA; Mohamad K; Abdul Razak MR; Mohamed Ibrahim N
    Front Neurosci; 2017; 11():712. PubMed ID: 29326545
    [No Abstract]   [Full Text] [Related]  

  • 11. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical atrophy is associated with cognitive impairment in Parkinson's disease: a combined analysis of cortical thickness and functional connectivity.
    Zhu Y; Yang B; Zhou C; Gao C; Hu Y; Yin WF; Yin K; Zhu Y; Jiang G; Ren H; Pang A; Yang X
    Brain Imaging Behav; 2022 Dec; 16(6):2586-2600. PubMed ID: 36044168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation of non-motor symptoms and sleep on balance in Parkinson's disease patients with normal cognition and mild cognitive impairment.
    Saricaoglu M; Yilmaz NH; Ozer FF; Hanoglu L
    Ir J Med Sci; 2021 Nov; 190(4):1577-1584. PubMed ID: 33449322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Dong L; Chang Q; Ma J; Liu C; Guo D; Li X; Yang D; Fan Y; Liang K; Li D; Gu Q
    Neurosci Lett; 2023 May; 804():137219. PubMed ID: 37023526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interocular asymmetry of retinal change in Parkinson's disease.
    Zhang Y; Li Y; Lai C; Wang X; Luo F; Niu Y; Qin Y; Zhang Y; Zhang H
    Parkinsonism Relat Disord; 2024 Aug; 125():107037. PubMed ID: 38878445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Mild Cognitive Impairment in Parkinson's Disease by Magnetic Resonance Quantitative Susceptibility Mapping Combined Voxel-Wise and Radiomic Analysis.
    Zhao Y; Qu H; Wang W; Liu J; Pan Y; Li Z; Xu G; Hu C
    Eur Neurol; 2022; 85(4):280-290. PubMed ID: 35313305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fist-Edge-Palm (FEP) test has a high sensitivity in differentiating dementia from normal cognition in Parkinson's disease.
    Liu Y; Qiu MY; Zhang YL; Zhang XJ; Truong D; Tan EK; Wu YC
    J Neurol Sci; 2021 Oct; 429():118060. PubMed ID: 34479167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease.
    Han L; Tang Y; Bai X; Liang X; Fan Y; Shen Y; Huang F; Wang J
    Aging (Albany NY); 2020 Jul; 12(13):13518-13528. PubMed ID: 32649312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
    Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
    Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.